Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients
Overall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months ...
Read moreOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months ...
Read moreWarrior Met Coal, Inc. (HCC) CEO Walter Scheller on Q3 2021 Results - Earnings Call Transcript
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline